(Total Views: 765)
Posted On: 12/10/2020 4:26:42 PM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
CD-12 update:
-371 patients
-5-6 patients a day enrolling
-had a record 15 patients enrolled in a single day
-should be finished by this weekend
-because enrollment is so fast, there will be no interim analysis
long-hauler trial update:
-expect "incredible" data
-will do interim analysis after 60 (?) patients
-close to submitting final comments for approval to proceed
-expect 7m patients for this indication, including younger patients
-identified long-hauler MOA
EUA for Philippines:
-not filed yet
-hope to file in a couple weeks with CD10 data (and maybe blinded CD12 data)
NASH update:
-new partnership with a UK diagnostic company for NASH
-believe that we can address both NASH and fatty liver disease
Cancer update:
-5 colon cancer patients (1 deceased)
-2 prostate cancer patients
-5 breast cancer patients
-8 patients are at least 4 months along
-hired new oncologist
HIV update:
-may file with EU (in addition to US, UK, and Canada)
-received detailed feedback on application
-high probability of success
HIV cure:
-developing protocol for trial
Vyrologix once-a-month treatment:
-strong potential for once-a-month treatment for prep
NASDAQ update:
-application is on hold (not rejected)
-still dealing with equity requirement and stock price requirement (and tangible assets requirement)
-371 patients
-5-6 patients a day enrolling
-had a record 15 patients enrolled in a single day
-should be finished by this weekend
-because enrollment is so fast, there will be no interim analysis
long-hauler trial update:
-expect "incredible" data
-will do interim analysis after 60 (?) patients
-close to submitting final comments for approval to proceed
-expect 7m patients for this indication, including younger patients
-identified long-hauler MOA
EUA for Philippines:
-not filed yet
-hope to file in a couple weeks with CD10 data (and maybe blinded CD12 data)
NASH update:
-new partnership with a UK diagnostic company for NASH
-believe that we can address both NASH and fatty liver disease
Cancer update:
-5 colon cancer patients (1 deceased)
-2 prostate cancer patients
-5 breast cancer patients
-8 patients are at least 4 months along
-hired new oncologist
HIV update:
-may file with EU (in addition to US, UK, and Canada)
-received detailed feedback on application
-high probability of success
HIV cure:
-developing protocol for trial
Vyrologix once-a-month treatment:
-strong potential for once-a-month treatment for prep
NASDAQ update:
-application is on hold (not rejected)
-still dealing with equity requirement and stock price requirement (and tangible assets requirement)
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)